Ribavirin Dose Optimization for the Treatment of Hepatitis C: A Pilot Study
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrial.gov record..
- 02 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.